Oxaliplatin vs. cisplatin: competition experiments on their binding to lysozyme.

作者: Daniela Marasco , Luigi Messori , Tiziano Marzo , Antonello Merlino

DOI: 10.1039/C5DT01279A

关键词:

摘要: The model protein hen egg white lysozyme was challenged with oxaliplatin and cisplatin. ESI mass spectrometry, surface plasmon resonance thermal shift analyses demonstrate the formation of a bis-platinum adduct, though in very small amounts. Crystals adduct were obtained using two different preparations X-ray structures solved at 1.85 A 1.95 resolution. Overall, data point out that, under analyzed conditions, Pt drugs have similar affinities for protein, but bind on its non-overlapping sites. In other words, these manifest significantly reactivity this do not compete same binding

参考文章(44)
Zbyszek Otwinowski, Wladek Minor, Processing of X-ray diffraction data collected in oscillation mode Methods in Enzymology. ,vol. 276, pp. 307- 326 ,(1997) , 10.1016/S0076-6879(97)76066-X
Uta-Maria Ohndorf, Mark A. Rould, Qing He, Carl O. Pabo, Stephen J. Lippard, Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature. ,vol. 399, pp. 708- 712 ,(1999) , 10.1038/21460
Dong Wang, Stephen J. Lippard, Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery. ,vol. 4, pp. 307- 320 ,(2005) , 10.1038/NRD1691
O. Pinato, C. Musetti, C. Sissi, Pt-based drugs: the spotlight will be on proteins Metallomics. ,vol. 6, pp. 380- 395 ,(2014) , 10.1039/C3MT00357D
R. A. Laskowski, M. W. MacArthur, D. S. Moss, J. M. Thornton, PROCHECK: a program to check the stereochemical quality of protein structures Journal of Applied Crystallography. ,vol. 26, pp. 283- 291 ,(1993) , 10.1107/S0021889892009944
Ryan C. Todd, Stephen J. Lippard, Inhibition of transcription by platinum antitumor compounds Metallomics. ,vol. 1, pp. 280- 291 ,(2009) , 10.1039/B907567D
Luigi Messori, Maria Agostina Cinellu, Antonello Merlino, Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.). ACS Medicinal Chemistry Letters. ,vol. 5, pp. 1110- 1113 ,(2014) , 10.1021/ML500231B
Angela Casini, Guido Mastrobuoni, Claudia Temperini, Chiara Gabbiani, Simona Francese, Gloriano Moneti, Claudiu T. Supuran, Andrea Scozzafava, Luigi Messori, ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme Chemical Communications. ,vol. 2, pp. 156- 158 ,(2007) , 10.1039/B611122J
G. Mathé, Y. Kidani, M. Segiguchi, M. Eriguchi, G. Fredj, G. Peytavin, J.L. Misset, S. Brienza, F. de Vassals, E. Chenu, C. Bourut, Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum Biomedicine & Pharmacotherapy. ,vol. 43, pp. 237- 250 ,(1989) , 10.1016/0753-3322(89)90003-6
Olivier Rixe, Waldo Ortuzar, Manuel Alvarez, Ricardo Parker, Eddie Reed, Ken Paull, Tito Fojo, Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel Biochemical Pharmacology. ,vol. 52, pp. 1855- 1865 ,(1996) , 10.1016/S0006-2952(97)81490-6